Literature DB >> 23830113

Herd-level risk factors for Campylobacter fetus infection, Brucella seropositivity and within-herd seroprevalence of brucellosis in cattle in northern Nigeria.

H M Mai1, P C Irons, J Kabir, P N Thompson.   

Abstract

Brucellosis and campylobacteriosis are economically important diseases affecting bovine reproductive efficiency in Nigeria. A questionnaire-based survey was conducted in 271 cattle herds in Adamawa, Kaduna and Kano states of northern Nigeria using multistage cluster sampling. Serum from 4745 mature animals was tested for Brucella antibodies using the Rose-Bengal plate test and positives were confirmed in series-testing protocol using competitive enzyme-linked immunosorbent assay. Preputial scrapings from 602 bulls were tested using culture and identification for Campylobacter fetus. For each disease, a herd was classified as positive if one or more animals tested positive. For each herd, information on potential managemental and environmental risk factors was collected through a questionnaire administered during an interview with the manager, owner or herdsman. Multiple logistic regression models were used to model the odds of herd infection for each disease. A zero-inflated Poisson model was used to model the count of Brucella-positive animals within herds, with the number tested as an exposure variable. The presence of small ruminants (sheep and/or goats) on the same farm, and buying-in of >3 new animals in the previous year or failure to practice quarantine were associated with increased odds of herd-level campylobacteriosis and brucellosis, as well as increased within-herd counts of Brucella-positive animals. In addition, high rainfall, initial acquisition of animals from markets, practice of gynaecological examination and failure to practice herd prophylactic measures were positively associated with the odds of C. fetus infection in the herd. Herd size of >15, pastoral management system and presence of handling facility on the farm were associated with increased odds, and gynaecological examination with reduced odds of herd-level Brucella seropositivity. Furthermore, the zero-inflated Poisson model showed that borrowing or sharing of bulls was associated with higher counts, and provision of mineral supplement with lower counts of Brucella-positive cattle within herds. Identification of risk factors for bovine campylobacteriosis and brucellosis can help to identify appropriate control measures, and the use of zero-inflated count model can provide more specific information on these risk factors.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brucella; Campylobacter fetus; Logistic regression; Northern Nigeria; Risk factors; Zero-inflated Poisson regression

Mesh:

Substances:

Year:  2013        PMID: 23830113     DOI: 10.1016/j.prevetmed.2013.05.016

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  10 in total

1.  Prevalence and risk factors associated with bovine genital campylobacteriosis and bovine trichomonosis in the state of Pernambuco, Brazil.

Authors:  Júnior Mário Baltazar de Oliveira; Gesika Maria da Silva; Antônio Fernando Barbosa Batista Filho; Jonas de Melo Borges; Pollyanne Raysa Fernandes de Oliveira; Daniel Friguglietti Brandespim; Rinaldo Aparecido Mota; José Wilton Pinheiro
Journal:  Trop Anim Health Prod       Date:  2015-01-30       Impact factor: 1.559

2.  Dairy farm demographics and management factors that played a role in the re-emergence of brucellosis on dairy cattle farms in Fiji.

Authors:  Andrew Tukana; B Gummow
Journal:  Trop Anim Health Prod       Date:  2017-05-20       Impact factor: 1.559

3.  A mixed methods study of ruminant brucellosis in central-eastern Tunisia.

Authors:  Mohamed Barkallah; Yaakoub Gharbi; Sonia Zormati; Nesrine Karkouch; Zouhir Mallek; Michel Gautier; Radhouane Gdoura; Imen Fendri
Journal:  Trop Anim Health Prod       Date:  2016-10-01       Impact factor: 1.559

4.  Brucellosis, genital campylobacteriosis and other factors affecting calving rate of cattle in three states of Northern Nigeria.

Authors:  Hassan M Mai; Peter C Irons; Peter N Thompson
Journal:  BMC Vet Res       Date:  2015-01-20       Impact factor: 2.741

5.  First isolation, identification, phenotypic and genotypic characterization of Brucella abortus biovar 3 from dairy cattle in Tanzania.

Authors:  C Mathew; M Stokstad; T B Johansen; S Klevar; R H Mdegela; G Mwamengele; P Michel; L Escobar; D Fretin; J Godfroid
Journal:  BMC Vet Res       Date:  2015-07-21       Impact factor: 2.741

6.  A case-control study of risk factors for bovine brucellosis seropositivity in Peninsular Malaysia.

Authors:  Mukhtar Salihu Anka; Latiffah Hassan; Siti Khairani-Bejo; Mohamed Abidin Zainal; Ramlan Bin Mohamad; Annas Salleh; Azri Adzhar
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

7.  Prevalence, distribution and risk factors for brucellosis infection in goat farms in Ningxiang, China.

Authors:  Yin Li; Dan Tan; Shuang Xue; Chaojian Shen; Huajie Ning; Chang Cai; Zengzai Liu
Journal:  BMC Vet Res       Date:  2021-01-19       Impact factor: 2.741

Review 8.  Prevalence and Antibiotic Resistance in Campylobacter spp. Isolated from Humans and Food-Producing Animals in West Africa: A Systematic Review and Meta-Analysis.

Authors:  Ellis Kobina Paintsil; Linda Aurelia Ofori; Sarah Adobea; Charity Wiafe Akenten; Richard Odame Phillips; Oumou Maiga-Ascofare; Maike Lamshöft; Jürgen May; Kwasi Obiri Danso; Ralf Krumkamp; Denise Dekker
Journal:  Pathogens       Date:  2022-01-24

Review 9.  Epidemiology and antimicrobial resistance of Campylobacter spp. in animals in Sub-Saharan Africa: A systematic review.

Authors:  Delfina Fernandes Hlashwayo; Betuel Sigaúque; Custódio Gabriel Bila
Journal:  Heliyon       Date:  2020-03-09

10.  The spatiotemporal distribution of human brucellosis in mainland China from 2007-2016.

Authors:  Peifeng Liang; Yuan Zhao; Jianhua Zhao; Dongfeng Pan; Zhongqin Guo
Journal:  BMC Infect Dis       Date:  2020-03-27       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.